Catamount Wealth Management’s Teva Pharmaceutical Industries TEVA Stock Holding History
Bought
Maintained
Sold
Other funds holding TEVA
NC
Catamount Wealth Management's TEVA Position: Q3 2017 in Review
Catamount Wealth Management sold out of Teva Pharmaceutical Industries (TEVA) in Q3 2017, closing a stake of 2,000 shares — an estimated $66K sold.
Catamount Wealth Management first reported a position in TEVA in Q3 2015 and held it in 8 quarters. The position peaked at $986K in Q2 2016. 538 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.
- Catamount Wealth Management reported no remaining Teva Pharmaceutical Industries position as of Q3 2017 after selling out during the quarter.
- Catamount Wealth Management sold 2,000 Teva Pharmaceutical Industries shares in Q3 2017, an estimated $66K.
- Catamount Wealth Management first reported a position in Teva Pharmaceutical Industries in Q3 2015 and held it in 8 quarters.
- Catamount Wealth Management's Teva Pharmaceutical Industries position peaked at $986K in Q2 2016.
- 538 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2017.
Based on Catamount Wealth Management's 13F filing for Q3 2017, filed 13 Nov 2017.